Navigation Links
Regional Biotech Association Warns Legislation Would Make VT Least Friendly State in Nation for Biotechnology and Life Sciences
Date:4/24/2009

-Testimony To Legislature Calls For Rejection Of Legislation That Will Cost Vermonters Current And Future Jobs-

MONTPELIER, Vt., April 24 /PRNewswire/ -- In testimony to the Legislature and a full page ad in today's Rutland Herald, the region's largest biotechnology association warned that a bill under consideration by the Vermont Legislature will create the most restrictive and onerous regulatory environment for biotechnology growth and development not only in New England, but in the entire nation. S. 48/H. 270 is the subject of a hearing in Montpelier today.

"Plain and simple, this legislation will harm Vermont's biotechnology and life sciences sector and drive jobs away," said Paula Newton, Chair of the New England Biotech Association (NEBA).

NEBA serves as the regional policy and public affairs voice for the biotechnology and biopharmaceutical community, representing state biotech associations, companies, academic institutions, and other organizations consisting of more than 800 entities.

"Vermont already has one of the strictest pharmaceutical marketing disclosure laws in the country, so the onerous regulatory regime contemplated by the Legislation is wholly unnecessary and should be defeated," continued Newton. "Physicians are trusted professionals, and introducing unreasonably broad controls and prohibitions on the interactions between the biopharmaceutical industry and doctors is unwarranted and contrary to health interests of Vermonters who stand to benefit from miracle drugs." She said the legislation would also eliminate existing protections of trade secrets, create an unneeded new state bureaucracy, and drive away research funding by mandating additional disclosure of expenditures.

Four other states, including New England states Maine and Rhode Island, have recently rejected marketing restriction legislation far less extreme than the Vermont bill, declaring the measures as bad policy with negative consequences for the life sciences industry and the jobs it produces. An overly restrictive disclosure law recently passed in Massachusetts --- less strict than the Vermont proposal -- has resulted in a drop in clinical trials and the cancellation of a major medical convention and the associated tourism and tax revenue.

NEBA is a non-profit, member-driven organization comprised of state biotech associations, companies, academic institutions, and other organizations with a collective mission to support and grow the biotechnology industry in New England.

To find out more about NEBA and view a copy of the Rutland Herald ad, visit www.newenglandbiotech.org


'/>"/>
SOURCE New England Biotech Association
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Defeat Autism Now!(R) Regional Conference to be Held in Oklahoma June 13-14, 2009
2. Midwest Research Institute Expands in Kansas to Support Regional Economic Development in Animal Health, Biosecurity, and Bioenergy Sectors
3. Regional Biotech Association Warns Vermont Legislation Could Have Profound Negative Impact
4. Shasta Regional Medical Center Awarded Full Accreditation from the Joint Commission
5. New Regional Biotech Association Formed
6. China Biopharma Reaches Agreement with a Regional Pharma to Launch New Pharmaceutical Products
7. Hcareers.com Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition
8. BioSpace.com Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition
9. JobLoft.com Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition
10. onTargetjobs Announces Acquisition of RegionalHelpWanted.com
11. A Magnetic Gift: Sumter Regional Hospital Receives New MRI as Charitable Donation From Siemens
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... ... 19, 2017 , ... VetStem Biopharma ’s CEO and founder, Dr. Bob Harman DVM, MPVM, ... book "Stem Cell Therapy: A Rising Tide". Dr. Harman and Dr. Riordan met in ... an interest in the potential of stem cell therapy and a fast friendship was formed. ...
(Date:9/19/2017)... ... September 19, 2017 , ... Avomeen Analytical ... recipients of its 2017 Science Student Award. The scholarship program is dedicated to ... community service defray the costs of obtaining their science education. , Avomeen began ...
(Date:9/18/2017)... ... 2017 , ... Transportable biomass conversion facilities and the economics ... the topic of a September 27 webinar hosted by the Waste ... biomass conversion facilities for producing biochar, briquettes, and torrefied wood, biomass supply chains ...
(Date:9/17/2017)... ... September 17, 2017 , ... GeneOne Life Science, Inc. ... and Drug Safety (KMFDS) for an Investigational New Drug application for a Phase ... coronavirus (MERS-CoV). The study in Korea represents the second clinical trial for GLS-5300. ...
Breaking Biology Technology:
(Date:4/5/2017)... Today HYPR Corp. , leading innovator ... of the HYPR platform is officially FIDO® Certified ... architecture that empowers biometric authentication across Fortune 500 enterprises ... over 15 million users across the financial services industry, ... product suites and physical access represent a growing portion ...
(Date:3/30/2017)... 30, 2017 The research team of The ... (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae recovery ... of speed and accuracy for use in identification, crime investigation, immigration ... ... A research team ...
(Date:3/24/2017)... The Controller General of Immigration from Maldives Mr. Mohamed Anwar ... prestigious international IAIR Award for the most innovative high security ePassport and ... ... Maldives Immigration Controller General, Mr. Mohamed ... the right) have received the IAIR award for the "Most innovative high ...
Breaking Biology News(10 mins):